Advanced Filters
noise

A, Kuopio N Clinical Trials

A listing of A, Kuopio N clinical trials actively recruiting patients volunteers.

Found 11,558 clinical trials

A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)

This goal of this trial is to learn about two medicines, enlicitide and rosuvastatin, in healthy people. Researchers will compare the amounts of enlicitide and rosuvastatin in a person's body over time, when they are given as separate medicines and when they are combined into one tablet.

18 - 55 years of age All Phase 1

A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors

This is a Phase 1/2 open label study consisting of dose escalation cohorts (Phase 1) followed by expansion cohorts (Phase 2). The Phase 1 dose escalation population includes subjects with advanced solid tumors that are refractory to standard of care therapy or for whom no standard of care options are …

18 years of age All Phase 1/2
Z Zhimin Shao

A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer

This is a Phase II clinical study aimed at evaluating the safety, tolerability, antitumor efficacy, PK and immunogenicity of AK146D1 combined with AK112 in advanced breast cancer.

18 - 75 years of age All Phase 2
P Peizeng Yang, Doctor

A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.

This study is designed to evaluate the efficacy and safety of GenSci048 compared with placebo in subjects with active non-infectious uveitis.

18 years of age All Phase 2
s shuhua Yuan, PhD

Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy

The goal of this clinical trial is to evaluate the efficacy and safety of hyperbaric oxygen (HBO)in stroke patients after endovascular treatment The main questions it aims to answer is: Whether HBO can improve the prognosis of ischemic stroke patients after endovascular treatment? 3. Participants will: receive HBO (1.6 Atmosphere …

35 - 75 years of age All Phase N/A
J Jiayang Yan, Ph.D

REGEND001 Autologous Basal Layer Stem Cell Transplantation for Bronchiectasis: A Translational Application Study

This clinical trial aims to evaluate the safety and efficacy of REGEND001, an autologous basal layer stem cell transplantation therapy, in patients with chronic structural lung disease (bronchiectasis). The treatment involves harvesting bronchial basal layer stem cells from the patient, expanding them ex vivo, and reintroducing them via bronchoscopic infusion …

25 - 80 years of age All Phase 1
A Ashley D Kendall, PhD

Multi-Site Feasibility Testing a Meditation App for Youth in the Legal System

This multi-site feasibility clinical trial aims to assess the feasibility of implementing a 1-month app-based meditation program with youth in 4 heterogeneous juvenile legal systems across Oregon and New York. The primary question it is designed to answer is: Will youth adequately adhere to the 1-month meditation app across sites? …

13 - 20 years of age All Phase N/A

A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers

The trial is designed to evaluate the pharmacokinetics, safety, tolerability, and immunogenicity of AMG 691 in healthy Chinese and Japanese participants

18 - 60 years of age All Phase 1
X Xiaohua Wu, M.D

A Phase I/IIa Study of SYS6041 in Patients With Advanced Solid Tumors

This trial is the first-in-human study of SYS6041, a multicenter, open-label, dose-escalation, dose-reassignment and cohort-expansion Phase I/IIa clinical study, which aims to evaluate the safety, tolerability, pharmacokinetic (PK) profile and preliminary antitumor efficacy of SYS6041 in participants with advanced solid tumors.

18 years of age All Phase 1/2
Z Zhengbo Song, MD

A Phase I Trial of GW01-200 Tablets in Subjects With Advanced Tumors

A phase 1, open-label, first-in-human study mainly aimed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of GW01-200 tablets in participants with advanced tumors, including solid tumors and hematological malignancies.

18 years of age All Phase 1

Simplify language using AI